Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Pyxis Oncology, Inc. (PYXS) had Free Cash Flow per Share of $-0.41 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-23.27M |
|
-- |
|
-- |
|
$24.36M |
|
$-24.36M |
|
$1.09M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-24.36M |
|
$-24.14M |
|
63.47M |
|
63.47M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$45.57M |
|
$7.54M |
|
$18.73M |
|
$64.30M |
|
$16.53M |
|
-- |
|
$16.50M |
|
$33.03M |
|
$31.27M |
|
$31.27M |
|
$31.27M |
|
62.83M |
|
| Cash Flow Statement Financials | |
$-26.00M |
|
$16.37M |
|
$-0.03M |
|
$16.89M |
|
$7.24M |
|
$-9.66M |
|
$1.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-74.43% |
|
-74.43% |
|
-36.19% |
|
-74.43% |
|
$0.50 |
|
|
Free Cash Flow per Share |
$-0.41 |
$-0.41 |
|